Effect of Interventions Aimed at Reducing or Modifying Saturated Fat Intake on Cholesterol, Mortality, and Major Cardiovascular Events
Annals of Internal Medicine · 2026-02 · 179 (2) · 242-255
DOI: 10.7326/annals-25-02229 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Annals of Internal Medicine, 2026-02. Verfasst von Jeremy P Steen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada (J.P.S.). Hauptthemen laut MEDLINE: Cardiovascular Diseases, Dietary Fats, Fatty Acids, Cholesterol. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Debates about optimal saturated fat advice continue. PURPOSE: To systematically summarize randomized trial data on reducing or modifying saturated fat intake on cholesterol, mortality, and major cardiovascular events. DATA SOURCES: MEDLINE, Embase, and Cochrane Central Register of Controlled Trials from inception to July 2025. STUDY SELECTION: Eligible trials enrolled adults with or without cardiovascular disease and studied the effect of reducing or modifying saturated fat intake. DATA EXTRACTION: Standard Cochrane methods. DATA SYNTHESIS: There were 17 eligible trials (66 337 participants). Risk stratified evidence provides low to moderate certainty that reducing saturated fat intake may result in a reduction in all-cause mortality (risk ratio [RR], 0.96 [95% CI, 0.88 to 1.06]), cardiovascular mortality (RR, 0.93 [CI, 0.77 to 1.11]), nonfatal myocardial infarction (MI) (RR, 0.86 [CI, 0.70 to 1.06]), and fatal and nonfatal stroke (RR, 0.83 [CI, 0.58 to 1.19]). For persons at low baseline cardiovascular risk, absolute reductions were below our thresholds of importance (5 and 10 per 1000 persons followed over 5 years for fatal and nonfatal outcomes, respectively); for those at high risk, the benefits were above our thresholds, suggesting there may be important absolute reductions. The effects were more pronounced when replacing saturated fat with polyunsaturated fat for nonfatal MI (RR, 0.75 [CI, 0.58 to 0.99]; P for interaction = 0.05; moderate credibility of subgroup effect based on Instrument to assess the Credibility of Effect Modification Analyses assessments). LIMITATIONS: Data were limited on the replacement of saturated fat with monounsaturated fat or protein. Trials varied considerably in their efficacy in reducing saturated fat intake and in their replacement macronutrients and concomitant dietary interventions, and new trials are needed to clarify uncertainty. CONCLUSION: For persons at low cardiovascular risk, reducing or modifying saturated fat intake has little or no benefit over a period of 5 years. Among persons at high cardiovascular risk, low- to moderate-certainty evidence was found for important reductions in mortality and major cardiovascular events, particularly for MI, with respect to replacing saturated fat with polyunsaturated fat. PRIMARY FUNDING SOURCE: None. (PROSPERO: CRD42023387377).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada (J.P.S.).
- Department of Nutrition Sciences and Toxicology, University of California, Berkeley, California; and Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada (K.C.K.).
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada (Y.C.).
- Department of Health Research Methods, Evidence, and Impact and Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; and MAGIC Evidence Ecosystem Foundation, Oslo, Norway (…
- School of Public Health and NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China (H.Z.).
- Department of Hygiene and Dietetics, Chair of Epidemiology and Preventive Medicine, Faculty of Medicine, and Systematic Reviews Unit, Jagiellonian University Medical College, Kraków, Poland (M.J.S., D.S., M.M.B.).
ORCID-Profile: Jeremy P Steen, Kevin C Klatt, Yaping Chang, Hongfei Zhu, Mateusz J Swierz, Dawid Storman, Long Ge, Lehana Thabane, Nirjhar R Ghosh, Pablo Alonso-Coello, Bradley C Johnston
Zitieren
APA
Steen, J. P., Klatt, K. C., Chang, Y., Guyatt, G. H., Zhu, H., Swierz, M. J., Storman, D., Sun, M., Zhao, Y., Ge, L., Thabane, L., Ghosh, N. R., Karam, G., Alonso-Coello, P., Bala, M. M., & Johnston, B. C. (2026). Effect of Interventions Aimed at Reducing or Modifying Saturated Fat Intake on Cholesterol, Mortality, and Major Cardiovascular Events. Annals of Internal Medicine, 179(2), 242-255. https://doi.org/10.7326/annals-25-02229
Vancouver
Steen JP, Klatt KC, Chang Y, Guyatt GH, Zhu H, Swierz MJ, et al. Effect of Interventions Aimed at Reducing or Modifying Saturated Fat Intake on Cholesterol, Mortality, and Major Cardiovascular Events. Annals of Internal Medicine. 2026;179(2):242-255. doi:10.7326/annals-25-02229
BibTeX
@article{Steen2026,
author = {Steen, Jeremy P and Klatt, Kevin C and Chang, Yaping and Guyatt, Gordon H and Zhu, Hongfei and Swierz, Mateusz J and Storman, Dawid and Sun, Mingyao and Zhao, Yunli and Ge, Long and Thabane, Lehana and Ghosh, Nirjhar R and Karam, Giorgio and Alonso-Coello, Pablo and Bala, Malgorzata M and Johnston, Bradley C},
title = {Effect of Interventions Aimed at Reducing or Modifying Saturated Fat Intake on Cholesterol, Mortality, and Major Cardiovascular Events},
journal = {Annals of Internal Medicine},
year = {2026},
volume = {179},
number = {2},
pages = {242--255},
doi = {10.7326/annals-25-02229}
}
EUVIMED